Audrey Lasek
Lille, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Can Systemic Treatment for Childhood Psoriasis Be Stopped in Cases of Remission? Data From the ACMe Cohort.
Journal: Pediatric dermatology
Published: November 06, 2025
Real-World Systemic Treatment Patterns and Outcomes of Children With Severe Alopecia Areata: A French Nationwide Study (ESTAPED ohort).
Journal: Paediatric drugs
Published: September 22, 2025
Dupilumab treatment in children aged 6 months to 5 years with severe atopic dermatitis.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: August 04, 2025
Drug survival of systemic treatments for severe paediatric psoriasis: An international retrospective study.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: December 16, 2024
Ocular surface evaluation in atopic dermatitis patients on dupilumab: A prospective observational study.
Journal: Journal francais d'ophtalmologie
Published: October 02, 2024
Impact of excess weight on clinical features of psoriasis and efficacy of biologic therapies in children with severe psoriasis: Analysis of data from the BiPe cohorts.
Journal: Annales de dermatologie et de venereologie
Published: October 18, 2023
Effectiveness of a nurse-led one-to-one education programme in addition to standard care in children with atopic dermatitis: a multicentre randomized control trial.
Journal: The British journal of dermatology
Published: June 12, 2023
Effectiveness of biologic therapies in children with palmoplantar plaque psoriasis: An analysis of real-life data from the BiPe cohorts.
Journal: Pediatric dermatology
Published: March 21, 2023
Effectiveness and tolerance of Janus kinase inhibitors for the treatment of recalcitrant atopic dermatitis in a real-life French multicenter adult cohort.
Journal: Journal of the American Academy of Dermatology
Published: May 07, 2022
Children with psoriasis and COVID-19: factors associated with an unfavourable COVID-19 course, and the impact of infection on disease progression (Chi-PsoCov registry).
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: March 18, 2022
Effectiveness and Safety of Adalimumab, Etanercept and Ustekinumab for Severe Psoriasis in Children Under 12 Years of Age: A French-Italian Daily Practice Cohort (BiPe Jr).
Journal: Paediatric drugs
Published: March 13, 2022
Effectiveness and safety of dupilumab in the treatment of atopic dermatitis in children (6-11 years): data from a French multicentre retrospective cohort in daily practice.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: January 06, 2022
Last Updated: 09/26/2026